|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-7-7
|
|
pubmed:abstractText |
Vein allografts are an alternative conduit for patients lacking available autogenous vein. The ability to develop a neoendothelium is a potential advantage of allografts over other nonautogenous grafts, because endothelial cells have been shown to play numerous essential roles in vessel survival. However, repopulation by endothelial cells has not previously been demonstrated or characterized in human subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0741-5214
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
994-1002
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10805891-Cell Division,
pubmed-meshheading:10805891-Cryopreservation,
pubmed-meshheading:10805891-Endothelium, Vascular,
pubmed-meshheading:10805891-Female,
pubmed-meshheading:10805891-Graft Rejection,
pubmed-meshheading:10805891-Humans,
pubmed-meshheading:10805891-Ischemia,
pubmed-meshheading:10805891-Leg,
pubmed-meshheading:10805891-Male,
pubmed-meshheading:10805891-Muscle, Smooth, Vascular,
pubmed-meshheading:10805891-Prospective Studies,
pubmed-meshheading:10805891-Saphenous Vein,
pubmed-meshheading:10805891-Sex Factors,
pubmed-meshheading:10805891-Transplantation, Homologous
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Cellular repopulation of human vein allograft bypass grafts.
|
|
pubmed:affiliation |
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
